1. Home
  2. FOCL vs TP Comparison

FOCL vs TP Comparison

Compare FOCL & TP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EDAP TMS S.A. American Depositary Shares

FOCL

EDAP TMS S.A. American Depositary Shares

N/A

Current Price

$2.96

Market Cap

206.3M

Sector

Health Care

ML Signal

N/A

TP

Ticketplus Ltd.

N/A

Current Price

$8.40

Market Cap

246.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FOCL
TP
Founded
1979
2014
Country
France
Chile
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.3M
246.4M
IPO Year
1998
2026

Fundamental Metrics

Financial Performance
Metric
FOCL
TP
Price
$2.96
$8.40
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$8.30
★ $14.50
AVG Volume (30 Days)
★ 60.6K
23.6K
Earning Date
11-05-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $70,527,000.00
N/A
Revenue This Year
N/A
$74.96
Revenue Next Year
$33.55
$23.91
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1.63
N/A
52 Week Low
$2.80
$6.10
52 Week High
$6.40
$12.14

Technical Indicators

Market Signals
Indicator
FOCL
TP
Relative Strength Index (RSI) 30.83 51.65
Support Level N/A $7.05
Resistance Level $4.56 $9.58
Average True Range (ATR) 0.31 0.74
MACD -0.10 0.03
Stochastic Oscillator 9.20 65.72

Price Performance

Historical Comparison
FOCL
TP

About FOCL EDAP TMS S.A. American Depositary Shares

Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.

Share on Social Networks: